HonCode

Go Back   HER2 Support Group Forums > General Cancer News
Reload this Page Positive results from Synta's Ganetespib Phase 2 trial on HER2-positive and triple ne
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply
 
Thread Tools Display Modes
Old 12-09-2011, 12:03 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 19,721
Positive results from Synta's Ganetespib Phase 2 trial on HER2-positive and triple ne
Synta Pharmaceuticals Corp. - Ganetespib, a potent, second generation Hsp90 inhibitor, has demonstrated clinical activity in heavily pre-treated patients with HER2-positive and triple negative metastatic breast cancer according to Phase 2 clinical trial results presented by researchers from Memorial Sloan-Kettering Cancer Center at the San Antonio Breast Cancer Symposium.

More...
News is offline   Reply With Quote
Reply

« Previous Thread | Next Thread »
Thread Tools
Display Modes
Hybrid Mode Hybrid Mode

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -7. The time now is 08:16 PM.
Contact Us - HER2 Support Group - Archive - Privacy Statement - Top

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter